How I manage resistant melasma?
Author(s) -
Suruchi Garg,
Ankita Tuknayat,
Titiksha Hans
Publication year - 2022
Publication title -
cosmoderma
Language(s) - English
Resource type - Journals
eISSN - 2769-5085
pISSN - 2768-6620
DOI - 10.25259/csdm_70_2021
Subject(s) - melasma , dermatology , rosacea , medicine , hyperpigmentation , telangiectasia , acne , refractory (planetary science) , physics , astrobiology
Melasma is a cosmetic disorder with profound psychological impact. Multiple therapies are available for melasma but no therapy is the gold standard. The most of the patients suffer from relapses and recurrences which force the patient to opt for over-the-counter medications containing topical steroids or indigenous medications. Use of these has led to the emergence of complicated cases of melasma which are refractory to the treatment. Along with hyperpigmentation, such patients also have steroid-induced side effects such as rosacea, atrophy of skin, and telangiectasia. Many patients develop exogenous ochronosis due to prolonged use of hydroquinone-based therapies. The present article focuses on the management of these cases of melasma.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom